CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	76.22B
Revenue (ttm)	1.93B
Net Income (ttm)	-52.24M
Shares Out	1.39B
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	186.14
Dividend	0.02 (0.04%)
Ex-Dividend Date	May 29, 2025

Volume	7,795,780
Average Volume	8,016,703
Open	54.00
Previous Close	54.73
Day's Range	52.28 - 55.15
52-Week Range	21.07 - 63.31
Beta	0.28
RSI	56.64
Earnings Date	Aug 16, 2025

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, Ch...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,487
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2024, SHE:300765's revenue was 1.98 billion, a decrease of -21.98% compared to the previous year's 2.54 billion. Earnings were 53.73 million, a decrease of -87.63%.